The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis

The re-emergence of tuberculosis in recent years led the World Health Organization (WHO) to launch the Stop TB Strategy program. Beside repurposing the existing drugs and exploring novel molecular combinations, an essential step to face the burden of tuberculosis will be to develop new drugs by identifying vulnerable bacterial targets. Recent studies have focused on decaprenylphosphoryl-d-ribose oxidase (DprE1) of Mycobacterium tuberculosis, an essential enzyme involved in cell wall metabolism, for which new promising molecules have proved efficacy as antitubercular agents. This review summarizes the state of the art concerning DprE1 in terms of structure, enzymatic activity and inhibitors. This enzyme is emerging as one of the most vulnerable target in M. tuberculosis.


Published in:
Applied Microbiology And Biotechnology, 97, 20, 8841-8848
Year:
2013
Publisher:
New York, Springer
ISSN:
0175-7598
Keywords:
Laboratories:




 Record created 2013-11-04, last modified 2018-03-17


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)